SCHEMBL28599148

SCHEMBL28599148

NC1CCCCNC(=O)C1

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 2/20 0.44
FKBP5 Q13451 1/20 0.44
OR51E2 Q9H255 1/20 0.41
KMT2A Q03164 1/20 0.33
CCR2 P41597 2/20 0.33
KDM4E B2RXH2 3/20 0.32
GAA P10253 1/20 0.32
POLB P06746 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4992808 0.98 FKBP5 (0.43) CRBNFKBP5OR51E2KMT2ACCR2
SCHEMBL4656366 0.93
SCHEMBL1128378 0.93
SCHEMBL9203626 0.93
Hydrochloric Acid SCHEMBL27846509 0.91 OR51E2 (0.41) CRBNFKBP5OR51E2KMT2AKDM4E
Hydrochloric Acid SCHEMBL26627502 0.91 OR51E2 (0.41) CRBNFKBP5OR51E2KMT2AKDM4E
SCHEMBL31681153 0.84
SCHEMBL4995896 0.84
SCHEMBL4988016 0.84
Hydrochloric Acid SCHEMBL9731033 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113234319-A Copolymerized nylon/graphene composite microsphere for selective laser sintering and preparation method thereof 贺州学院 2021-08-10 CN claimed
US-20250276979-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. 2025-09-04 US disclosed
CN-113234319-A Copolymerized nylon/graphene composite microsphere for selective laser sintering and preparation method thereof 贺州学院 2021-08-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250276979-A1 SARS-COV2 MAIN PROTEASE INHIBITORS ACE2, TMPRSS2, ACE CRBN 3830/4885FKBP5 1924/4885OR51E2 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.